Disease | multiple endocrine neoplasia type 1 |
Comorbidity | C0279626|esophageal squamous cell carcinoma |
Sentences | 1 |
PubMedID- 24124338 | Aim: to evaluate the efficacy and safety of paclitaxel-nedaplatin combination as a front-line regimen in chinese patients with metastatic esophageal squamous cell carcinoma (escc). |
Page: 1